43. THE SITUATION OF TUBERCULOSIS/HIV CO-INFECTION AMONG TB PATIENTS IN VIETNAM DURING THE PERIOD 2017-2023
Main Article Content
Abstract
Objective: To evaluate the situation and trends of tuberculosis/HIV co-infection among tuberculosis patients nationwide during the period 2017-2023.
Subjects and methods: Tuberculosis patients detected and managed nationwide during the period 2017-2023. A retrospective descriptive study utilized secondary data from the reporting system of the National Tuberculosis Control Program. Data were analyzed using Excel and Stata software, applying Chi-square tests with a 95% confidence interval.
Results: From 2017 to 2023, among 702,024 tuberculosis patients, 595,166 (84.8%) were tested for HIV, with the testing rate increasing from 82.9% in 2017 to 87.7% in 2023 (p < 0.05). The HIV-positive rate decreased from 3.7% in 2017 to 2.6% in 2023 (p < 0.05). A reduction in the HIV-positive rate was observed in most regions, except for the South-Central Coast and Central Highlands (p > 0.05).
Conclusions: HIV testing among tuberculosis patients has significantly improved but has not yet met the 90% target. The decreasing HIV-positive rate indicates that tuberculosis/HIV co-infection is being effectively controlled. The National Tuberculosis Control Program needs to strengthen HIV testing in 37 provinces and cities with rates below 90%.
Article Details
Keywords
Tuberculosis, tuberculosis/HIV trends, tuberculosis/HIV co-infection
References
[2] UNAIDS, UNAIDS 2023 Report: Global report 2023.
[3] Bộ Y tế, Quyết định số 162/QĐ-BYT năm 2024 về Hướng dẫn Chẩn đoán, điều trị và dự phòng bệnh lao, Hà Nội, ngày 27/9/2024.
[4] Bộ Y tế, Đẩy mạnh công tác sàng lọc, phát hiện bệnh đồng nhiễm lao/HIV, Hà Nội, 2024.
[5] World Health Organization, Global tuberculosis report 2017.
[6] World Health Organization, Global tuberculosis report 2024.
[7] World Health Organization, A guide to monitoring and evaluation for collaborative TB/HIV activities, World Health Organization, 2015, Available from: https://www.who.int/publications/i/item/9789241508278, Accessed 23 December 2024
[8] Kumar A.M.V, Gupta D, Kumar A, Gupta R.S, Kanchar A et al, HIV testing among patients with presumptive tuberculosis: how do we implement in a routine programmatic setting? Results of a large operational research from India, PLoS One, 2016, 11: e0156487.
[9] Liu E, Wang Q, Zhang G, Zhou L, Chen M, Tuberculosis/HIV coinfection and treatment trends - China, 2015-2019, China CDC Wkly, 2020 Nov 27, 2 (48): 924-928, doi: 10.46234/ccdcw2020.252.
[10] Kazemian S.V, Shakeri M, Nazar E, Nasehi M, Sharafi S, Dadgarmoghaddam M, Prevalence, treatment outcomes and determinants of TB/HIV coinfection: A 4-year retrospective review of national tuberculosis registry in a country in a MENA region, Heliyon, 2024 Feb 17, 10 (5): e26615, doi: 10.1016/j.heliyon.2024.e26615.